Health Imaging

JUNE 15, 2023

According to new research, gliomas—a deadly group of brain tumors that are difficult to treat—have increased folate receptor expression, meaning they also show increased uptake of folate-based radiopharmaceuticals on PET imaging.

Radiopharmaceuticals 106

Radiopharmaceuticals Imaging 106

Open Medscience

DECEMBER 31, 2023

Lutetium radiopharmaceuticals significantly advance targeted cancer treatment and diagnostic capabilities. The post Lutetium Radiopharmaceuticals in Medicine: A Comprehensive Review appeared first on Open Medscience.

Radiopharmaceuticals 59

Radiopharmaceuticals Diagnostic Medical Imaging 59

Open Medscience

NOVEMBER 16, 2023

In Brazil, the growing radiopharmaceutical market, driven by chronic disease and advanced imaging technologies, is becoming increasingly significant in healthcare. The post Advancing Healthcare: The Dynamic Growth of Brazil’s Radiopharmaceutical Market appeared first on Open Medscience.

Radiopharmaceuticals 59

Radiopharmaceuticals Healthcare Healthcare Disease 59

Imaging Technology

MAY 10, 2024

milla1cf Fri, 05/10/2024 - 08:08 May 10, 2024 — Mariana Oncology , a fully integrated biotechnology company pioneering a new era of radiopharmaceutical innovation to treat people with cancer , today announced it will be acquired by Novartis for $1 billion upfront and up to $750 million in potential milestone payments.

Radiopharmaceuticals 66

Radiopharmaceuticals Clinic IT 66

Open Medscience

NOVEMBER 11, 2023

Copper radiopharmaceuticals offer groundbreaking diagnostic and therapeutic applications, revolutionising nuclear medicine, particularly in oncology and cardiology. The post Exploring Copper Radiopharmaceuticals: Innovations and Applications in Nuclear Medicine appeared first on Open Medscience.

Nuclear Medicine 59

Nuclear Medicine Radiopharmaceuticals Diagnostic Medical 59

Open Medscience

MARCH 22, 2024

The post Nuclear Medicine at the Centre of Radiology and Radiopharmaceuticals appeared first on Open Medscience. Nuclear medicine and the future of precise, personalised care in diagnosing and treating diseases.

Nuclear Medicine 52

Nuclear Medicine Radiopharmaceuticals Radiology Disease 52

Imaging Technology

OCTOBER 17, 2023

a clinical stage radiopharmaceutical company focused on the discovery and development of novel agents for the treatment of a wide range of oncology indications, is pleased to announce that the first subject has been dosed in its Phase 1 study of 68Ga-R8760. milla1cf Tue, 10/17/2023 - 13:07 October 17, 2023 — Radionetics Oncology, Inc.,

Radiopharmaceuticals 111

Radiopharmaceuticals Clinic Disease Diagnose 111

AuntMinnie

MAY 8, 2024

Three clinical issues that may arise with theranostics treatments will require special provisions, including spot imaging, according to insights shared during the 124th annual meeting of the American Roentgen Ray Society (ARRS) in Boston. Spot imaging revealed that more than half of the administered activity was in the patient's arm.

Radiopharmaceuticals 75

Radiopharmaceuticals Nuclear Medicine Radiation Hospital 75

Imaging Technology

JANUARY 5, 2024

This leading radiopharmaceutical platform provides detailed PET imaging-based diagnosis and dosimetry using long-lived copper-64 ( 64 Cu) for imaging and alpha-particle targeted RPT using lead-212 ( 212 Pb). It can also be used for beta-particle targeted RPT using copper isotopes.

Radiopharmaceuticals 78

Radiopharmaceuticals Clinic Nuclear Medicine Radiation 78

AuntMinnie

JUNE 22, 2023

Read more on AuntMinnie.com Related Reading: RLS appoints new director of regulatory affairs SpectronRx, RLS ink radiopharmaceutical supply deal RLS lands radiopharmaceutical supplier deal from Premier Sofie to launch FAPI-PET phase II trial First patient imaged in Sofie's FAPI-PET trial

Radiopharmaceuticals 52

Radiopharmaceuticals Imaging 52

Imaging Technology

APRIL 5, 2024

milla1cf Fri, 04/05/2024 - 11:31 April 5, 2024 — RLS Radiopharmacies , America’s only Joint Commission-accredited radiopharmacy network, today announced it has expanded its radiopharmaceutical contract development and manufacturing (rCDMO) capabilities by entering into a strategic agreement with global isotope technology leader Eckert & Ziegler.

Radiopharmaceuticals 52

Radiopharmaceuticals Radiation Oncology Radiation Quality and Compliance 52

Diagnostic Imaging

JUNE 28, 2023

In a recent interview at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) conference in Chicago, Phillip Kuo, M.D.,

Radiopharmaceuticals 62

Radiopharmaceuticals Nuclear Medicine Imaging 62

Imaging Technology

SEPTEMBER 20, 2023

a therapeutic oncology company and 3B Pharmaceuticals (3BP) GmbH, a biotechnology company developing targeted radiopharmaceutical drugs and diagnostics for cancer detection and treatment, announced an exclusive licensing agreement for RefleXion to develop and commercialize a specific 3BP molecule to direct its SCINTIX biology-guided radiotherapy.

Pharmaceutical 96

Pharmaceutical Radiopharmaceuticals Radiation Diagnostic 96

AuntMinnie

SEPTEMBER 13, 2023

The Medical Imaging and Technology Alliance (MITA) has raised concerns ove. Senate MITA hails radiopharmaceutical legislation

Radiopharmaceuticals 52

Radiopharmaceuticals PET Scan Disease Medical Imaging 52

Imaging Technology

JUNE 15, 2023

The clinical trial will use this investigational radiopharmaceutical to help understand if patients have CD8+ T cells in their tumors and will, therefore, be more likely to respond to immune checkpoint inhibitors, the main class of immunotherapies currently approved for use. Lancet Oncology 2023; 24(3): e133-e143.

Radiopharmaceuticals 86

Radiopharmaceuticals Pharmaceutical Nuclear Medicine PET Scan 86

UCSF Biomedical Imaging

JANUARY 12, 2024

In 2003, the Center for Molecular and Functional Imaging (CMFI) at China Basin Landing opened its doors with San Francisco’s first 3T MRI and two 1.5T clinical scanners, followed a few years later by a cyclotron which launched our in-house radiopharmaceutical program.

Radiopharmaceuticals 122

Radiopharmaceuticals Imaging MRI Clinic 122

Open Medscience

JULY 28, 2019

Radiopharmaceuticals are used in nuclear medicine for the application of medical imaging and therapy. The post Radiopharmaceuticals used in nuclear medicine appeared first on Open Medscience.

Nuclear Medicine 52

Nuclear Medicine Radiopharmaceuticals Medical Imaging Medical 52

AuntMinnie

APRIL 4, 2024

Life Molecular Imaging (LMI) and Sofie Biosciences have begun offering the Neuraceq ( florbetaben F-18) PET radiotracer produced at Sofie's radiopharmaceutical manufacturing site in Cleveland, Ohio. With this expansion, LMI continues driving commercial sales of Neuraceq around the U.S.

Radiopharmaceuticals 95

Radiopharmaceuticals Imaging Disease Diagnostic 95

Imaging Technology

JANUARY 5, 2024

milla1cf Fri, 01/05/2024 - 11:32 January 5, 2024 — NorthStar Medical Radioisotopes, LLC , a global innovator in development, production and commercialization of radiopharmaceuticals used to detect and treat cancer and other serious diseases, and Curadh MTR Inc. Chief Executive Officer of NorthStar Medical Radioisotopes.

Radiopharmaceuticals 52

Radiopharmaceuticals Medical Nuclear Medicine Pharmaceutical 52

Health Imaging

JANUARY 8, 2024

The new facility is run by Novartis and is being called the “most advanced of its kind."

Radiopharmaceuticals 100

Radiopharmaceuticals IT 100

Imaging Technology

DECEMBER 6, 2023

and Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization of innovative PET radiopharmaceuticals, today provided additional information regarding a March 2022 licensing and collaboration agreement between Philochem and Blue Earth Diagnostics. Chief Executive Officer of Blue Earth Diagnostics.

Diagnostic 96

Diagnostic Diagnostic Imaging Clinic Radiopharmaceuticals 96

Open Medscience

JUNE 22, 2024

Radiotheranostics combines diagnostic imaging and targeted radiotherapy, using radiopharmaceuticals for personalised, precise cancer treatment and improved outcomes. The post What is Radiotheranostics? The Future of Personalised Cancer Diagnosis appeared first on Open MedScience.

Radiopharmaceuticals 52

Radiopharmaceuticals Diagnostic Imaging Diagnostic Imaging 52

Health Imaging

APRIL 5, 2024

The supply agreement with Eckert & Ziegler will ensure radiopharmaceuticals are available for PET imaging and cancer treatment plans.

Radiopharmaceuticals 103

Radiopharmaceuticals IT Imaging 103

Diagnostic Imaging

JUNE 9, 2024

shared her perspective on a number of topics affecting nuclear medicine, ranging from isotope availability and reimbursement challenges for diagnostic radiopharmaceuticals to increasing patient interest in PET imaging. In a recent interview, Cathy Cutler, Ph.D.,

Nuclear Medicine 70

Nuclear Medicine Radiopharmaceuticals Diagnostic Imaging 70

Imaging Technology

JUNE 10, 2024

The award was announced by the Society of Nuclear Medicine and Molecular Imaging (SNMMI) during its 2024 Annual Meeting, June 8-11 in Toronto. More recently, she and her collaborators developed a PET imaging agent for vaso-occlusive crisis in sickle cell disease, recently approved for human studies by the FDA as an Investigational New Drug.

Nuclear Medicine 81

Nuclear Medicine Radiopharmaceuticals Disease Imaging 81

AuntMinnie

JUNE 6, 2023

Read more on AuntMinnie.com Related Reading: KA Imaging lands radiography supply contract from Premier Premier gives Canon Supplier Legacy Award GE sells radiopharmacy network to RLS Elekta secures 5-year Premier contract Guerbet wins group purchasing agreement from Premier

Radiopharmaceuticals 52

Radiopharmaceuticals Nuclear Medicine Radiography Imaging 52

AuntMinnie

MARCH 7, 2024

In terms of 2023 spending, the average radiopharmaceutical expenditure per fixed PET site is estimated to be $517,000. In 2023, 38% of PET systems were operated by the PET department, 28% by nuclear medicine, 24% by radiology/imaging, 5% by radiation oncology, and 2% by molecular imaging. 1033 to speak with a representative.

PET Scan 116

PET Scan Nuclear Medicine Radiation Oncology Radiopharmaceuticals 116

Imaging Technology

JUNE 12, 2024

milla1cf Wed, 06/12/2024 - 21:58 June 12, 2024 — Cathy Sue Cutler, PhD, FSNMMI , chair of the Isotope Research and Production Department at Brookhaven National Laboratory in Upton, New York, has been named as president for the Society of Nuclear Medicine and Molecular Imaging (SNMMI).

Nuclear Medicine 106

Nuclear Medicine Radiopharmaceuticals Education Government 106

AuntMinnie

JUNE 5, 2024

NorthStar Medical Radioisotopes has completed a cleanroom facility at its campus in Beloit, WI, to support batch production of radiopharmaceuticals for research and treatment. The cleanroom at NorthStar's campus in Beloit, WI.

Radiopharmaceuticals 52

Radiopharmaceuticals Clinic Medical IT 52

AuntMinnie

DECEMBER 11, 2023

Key corporate members and staff from the Medical Imaging Technology Alliance (MITA) are launching a new medical imaging technology division at medical technology trade association Advanced Medical Technology Association (AdvaMed).

Imaging 111

Imaging Medical Imaging Radiopharmaceuticals Medical 111

Diagnostic Imaging

JANUARY 12, 2024

The FDA has accepted Lantheus' abbreviated new drug application for a generic Lutathera, just months after Novartis announced positive phase 3 data supporting a first-line indication for the radiopharmaceutical in neuroendocrine tumors.

Radiopharmaceuticals 127

Radiopharmaceuticals 127

AuntMinnie

MAY 30, 2023

Read more on AuntMinnie.com Related Reading: Blue Earth touts clinical results Blue Earth highlights results from PET tracer trial PET tracer shows promise in imaging of brain tumors Blue Earth touts PSMA radiotracer study Blue Earth moves toward U.K. prostate radiopharmaceutical licensing

Radiopharmaceuticals 52

Radiopharmaceuticals Imaging Diagnostic Clinic 52

AuntMinnie

APRIL 4, 2024

The RLS radiopharmacy network will use these generators to produce gallium-68-based (Ga-68) radiopharmaceuticals for PET imaging and treatment planning for patients with neuroendocrine tumors and prostate cancer.

Radiopharmaceuticals 52

Radiopharmaceuticals IT Medical Imaging 52

Imaging Technology

APRIL 28, 2023

Molecular imaging enables doctors and clinicians to see inside the body with a non-invasive process, helping to diagnose and treat diseases such as cancer, cardiovascular disease , and neurological diseases. It can allow early and precise diagnosis.

Healthcare 87

Healthcare Healthcare Radiopharmaceuticals PET Scan 87

Imaging Technology

JUNE 11, 2024

She will also raise awareness of nuclear medicine’s value to clinical colleagues and patients and will be laser-focused on breaking down barriers to radiopharmaceutical availability, reimbursement, affordability, and funding. SNMMI introduced a new slate of officers during its 2024 Annual Meeting, held June 8-11 in Toronto.

Nuclear Medicine 52

Nuclear Medicine Radiopharmaceuticals Patient Care Medical 52

Imaging Technology

DECEMBER 12, 2023

milla1cf Tue, 12/12/2023 - 10:00 December 12, 2023 — IBA , a world leader in particle accelerator technology and of radiopharmaceutical production solutions is pleased to announce the start of the installation of a Cyclone 30XP in Poland. Beyond At-211, IBA is also pioneering novel accelerator applications for other theranostic isotopes.

Radiopharmaceuticals 111

Radiopharmaceuticals Nuclear Medicine Clinic IT 111

AuntMinnie

JUNE 9, 2024

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has bestowed its Georg Charles de Hevesy Nuclear Pioneer award on Carolyn Anderson, PhD, of the University of Missouri-Columbia (MU). Image courtesy of SNMMI. Carolyn Anderson, PhD, of the University of Missouri-Columbia.

Nuclear Medicine 98

Nuclear Medicine Radiopharmaceuticals Disease Imaging 98